AccuSite injectable gel consisting of 5-fluorouracil and the vasoconstrictor epinephrine in bovine collagen matrix data

MATX (Menlo Park, Calif.) reported Phase II results in which all patients on a treatment schedule of three intralesional treatments per week for two weeks showed a complete response. MATX plans a Phase III trial using this dosing schedule. ...